"This analysis explores the critical shifts in the sector, highlighting a projected growth trajectory driven by technological integration and changing consumer dynamics."

According to analysts at Vantage Market Research, the United States Gynecological Devices Market size is worth USD 12.4 Billion in 2025 and is projected to reach USD 24.7 Billion by 2035, growing at a CAGR (Compound Annual Growth Rate) of 7.1% from 2026 to 2035. Key trends include rising adoption of minimally invasive gynecological procedures, robotic-assisted surgical technologies, growing demand for hysteroscopy and ablation devices, increasing fertility-related procedures, expansion of ambulatory surgical centers, advanced gynecological visualization systems, digital healthcare integration, and growing institutional investment in women’s healthcare infrastructure.

United States Gynecological Devices Market Overview

The United States Gynecological Devices Market is witnessing steady growth as healthcare providers modernize procedural infrastructure and increasingly adopt technologies designed to improve surgical precision, patient recovery, and operating room efficiency. Gynecological devices support a broad range of diagnostic and therapeutic procedures, including hysteroscopy, laparoscopy, endometrial ablation, uterine fibroid treatment, fertility procedures, cervical interventions, and other women’s healthcare applications.

The growing burden of gynecological conditions, including uterine fibroids and endometriosis, is supporting demand for specialized procedural devices. At the same time, healthcare providers are increasingly prioritizing minimally invasive approaches that can reduce recovery time, optimize operating room utilization, and improve procedural efficiency.

Surgical Devices currently represent the leading product category due to their broad utilization across gynecological interventions. Robotic-Assisted Devices are gaining momentum as hospitals expand precision-oriented surgical programs and invest in advanced minimally invasive capabilities. Fertility centers and specialty gynecology clinics are also creating additional demand for specialized diagnostic and reproductive health instrumentation.

Hospital consolidation and centralized procurement are further influencing market development. Integrated delivery networks increasingly seek standardized device portfolios and long-term vendor relationships to improve purchasing efficiency and clinical consistency. Group Purchasing Organizations also play an important role in institutional procurement, particularly among larger healthcare systems.

Ambulatory Surgical Centers are becoming increasingly important as selected gynecological procedures shift toward outpatient care. This transition is encouraging demand for compact, efficient, disposable, and minimally invasive technologies that support faster procedural turnover and lower facility utilization requirements.

Overall, the US Gynecological Devices Market is expected to maintain sustained growth as healthcare providers continue investing in advanced surgical systems, minimally invasive platforms, fertility-related technologies, and connected procedural infrastructure. The competitive environment remains active among diversified medical technology companies and specialized women’s health device manufacturers.

Hologic Expanded Advanced Hysteroscopic Systems for Outpatient Gynecology Centers

February 2025 — Hologic expanded advanced hysteroscopic systems for outpatient gynecology centers, supporting procedural modernization and broader adoption of minimally invasive gynecological interventions.

Key Takeaways from the Report

The growing prevalence of gynecological conditions and increasing procedural intervention volumes are supporting demand for advanced gynecological devices across hospitals, specialty clinics, fertility centers, and ambulatory surgical facilities.
Surgical Devices represented 34.8% of total market share, reflecting the continued importance of procedural intervention across hysteroscopy, laparoscopy, fibroid treatment, and other gynecological surgeries.
Robotic-Assisted Devices are advancing at a 9.3% CAGR as healthcare institutions increasingly prioritize precision, surgical dexterity, and minimally invasive operating workflows.
Endometriosis applications contributed 18.6% of procedural utilization, supported by increasing diagnosis and treatment requirements and growing use of specialized surgical technologies.
Minimally invasive device platforms are gaining strong traction as healthcare providers seek shorter recovery periods, improved procedural efficiency, and optimized operating room utilization.
Hospitals remain the dominant end-user segment because of their high procedural volumes, centralized procurement structures, and established surgical infrastructure.
Ambulatory Surgical Centers are expanding rapidly as healthcare providers increasingly shift appropriate gynecological procedures toward outpatient settings and seek technologies that support faster procedural turnover.
Fertility Centers represent an important growth opportunity as assisted reproductive procedures increase demand for specialized diagnostic and reproductive health instrumentation.
Group Purchasing Organizations accounted for 26.9% of institutional procurement channels, highlighting the importance of centralized purchasing strategies within major US healthcare networks.
Technological developments in robotic-assisted surgery, energy-based treatment, visualization, and digitally connected procedural systems are creating new opportunities for device manufacturers and healthcare providers.

Top Players

Medtronic plc
Boston Scientific Corporation
CooperSurgical Inc.
Hologic Inc.
Olympus Corporation
Karl Storz
Richard Wolf
Stryker Corporation
Johnson & Johnson
Ethicon
Braun
ConMed

Report Coverage

Our market research reports provide comprehensive insights that are essential for strategic decision-making. We cover all key aspects of the market, including dynamics such as drivers, restraints, opportunities, and challenges, alongside the latest industry trends. Our analysis includes an in-depth technology roadmap, product life cycle evaluation, and PESTLE analysis, ensuring a thorough understanding of the market environment. We also assess GDP growth outlooks, examine regional and national market landscapes, and evaluate the impact of major events such as the COVID-19 pandemic. Additionally, our reports feature a detailed competitive landscape, including company market shares and profiles, providing actionable intelligence to empower your business strategies.

Latest Announcement

June 2026 — Stryker expanded robotic-assisted compatibility across gynecological surgical instruments, supporting the broader integration of precision-led technologies into minimally invasive gynecological procedures.